IRIS UniCatt

Sora', Federica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.825
AS - Asia 5.694
EU - Europa 4.769
SA - Sud America 1.143
AF - Africa 174
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 5
Totale 18.623
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.625
SG - Singapore 2.593
CN - Cina 1.345
DE - Germania 1.296
BR - Brasile 929
IT - Italia 878
SE - Svezia 736
VN - Vietnam 501
FR - Francia 473
GB - Regno Unito 287
IE - Irlanda 254
IN - India 235
UA - Ucraina 203
FI - Finlandia 193
ID - Indonesia 183
BD - Bangladesh 144
JP - Giappone 136
RU - Federazione Russa 129
HK - Hong Kong 106
CA - Canada 86
TR - Turchia 79
AR - Argentina 77
KR - Corea 76
NL - Olanda 64
MX - Messico 63
IQ - Iraq 55
PL - Polonia 40
AT - Austria 34
SA - Arabia Saudita 32
ES - Italia 31
CI - Costa d'Avorio 30
EC - Ecuador 30
BE - Belgio 29
UZ - Uzbekistan 28
ZA - Sudafrica 28
IR - Iran 27
MA - Marocco 27
CZ - Repubblica Ceca 25
CL - Cile 22
CO - Colombia 22
PK - Pakistan 22
EG - Egitto 20
KE - Kenya 20
VE - Venezuela 18
CH - Svizzera 15
UY - Uruguay 15
JO - Giordania 14
PH - Filippine 14
AE - Emirati Arabi Uniti 12
AZ - Azerbaigian 12
IL - Israele 12
LT - Lituania 12
PE - Perù 12
PY - Paraguay 12
TN - Tunisia 11
AL - Albania 10
HU - Ungheria 10
JM - Giamaica 10
NP - Nepal 10
AU - Australia 9
DZ - Algeria 9
RO - Romania 9
LB - Libano 7
TT - Trinidad e Tobago 7
AO - Angola 6
DO - Repubblica Dominicana 6
ET - Etiopia 6
OM - Oman 6
PA - Panama 6
BG - Bulgaria 5
CR - Costa Rica 5
EE - Estonia 5
MY - Malesia 5
PT - Portogallo 5
SN - Senegal 5
TH - Thailandia 5
TW - Taiwan 5
BA - Bosnia-Erzegovina 4
BZ - Belize 4
KG - Kirghizistan 4
KZ - Kazakistan 4
QA - Qatar 4
SV - El Salvador 4
AM - Armenia 3
GE - Georgia 3
GR - Grecia 3
HN - Honduras 3
LI - Liechtenstein 3
MD - Moldavia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BH - Bahrain 2
BO - Bolivia 2
CG - Congo 2
GA - Gabon 2
GY - Guiana 2
HR - Croazia 2
LK - Sri Lanka 2
LV - Lettonia 2
Totale 18.589
Salva come PNG Salva come JPEG
Città #
Singapore 1.358
Ashburn 783
San Jose 721
Chandler 639
Beijing 264
Dublin 250
Hefei 206
Los Angeles 180
Woodbridge 180
Rome 176
Lauterbourg 163
Jakarta 161
Ho Chi Minh City 160
Jacksonville 159
San Mateo 137
Hanoi 129
Tokyo 129
Dearborn 125
Milan 119
New York 119
Frankfurt am Main 112
Munich 112
Nanjing 112
Wilmington 112
Houston 104
Tukwila 102
Hong Kong 97
Fairfield 91
Chicago 90
Hyderabad 89
Helsinki 85
Ann Arbor 84
Council Bluffs 82
The Dalles 81
Seattle 77
Boston 75
Moscow 72
Cattolica 71
Dallas 71
Santa Clara 69
Seoul 69
Florence 67
São Paulo 67
St Louis 63
Buffalo 62
Kent 58
Princeton 58
Redmond 57
Lancaster 53
Nürnberg 53
Nanchang 51
Marseille 50
Redwood City 50
Boardman 46
Lappeenranta 43
Paris 42
Lawrence 41
Atlanta 39
Bremen 39
Orem 39
Izmir 36
London 33
Toronto 31
Abidjan 30
Warsaw 30
Brussels 29
Rio de Janeiro 28
Brooklyn 27
Da Nang 27
Nuremberg 27
Shanghai 27
Kunming 25
Dhaka 24
Tashkent 24
Tianjin 24
Norwalk 23
Amsterdam 22
Belo Horizonte 22
Guangzhou 22
Phoenix 22
San Francisco 22
Baghdad 21
Denver 20
Manchester 20
Stockholm 20
Düsseldorf 18
Montreal 18
Philadelphia 18
Pune 18
Turku 18
Campinas 17
Hangzhou 17
Leawood 17
Mexico City 17
Nairobi 17
Porto Alegre 17
Brno 16
Cambridge 16
Chennai 16
Curitiba 16
Totale 9.885
Salva come PNG Salva come JPEG
Nome #
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 434
Reliability of leukostasis grading score to identify patients with high-risk hyperleukocytosis 383
Dasatinib first-line: Multicentric Italian experience outside clinical trials 295
Dasatinib first-line: Multicentric Italian experience outside clinical trials 294
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 290
Low-dose valganciclovir as preemptive therapy for cytomegalovirus infection occurring in allogeneic stem cell transplant recipients 223
Correlation between paraproteinaemia and viral reactivation after allo-SCT 216
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 211
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 189
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 180
Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia 177
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 176
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation 174
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 171
Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab. 167
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 164
EXTREME THROMBOCYTOSIS IN CHRONIC MYELOID LEUKEMIA IN THE ERA OF TYROSINE KINASE INHIBITORS 160
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 159
Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration 155
revalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience. 153
AB0 type does not affect platelet engraftment after autologous peripheral blood stem cell transplant in a series of 249 hematologic patients 152
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 152
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 149
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 148
H1N1 Influenza among Hematological Patients: Monocentric Influenza Cases from 2011 to 2016 147
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 147
Prevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience 143
Guillain-Barre' syndrome following Varicella zoster reactivation in Chronic Lymphocytic Leukemia treated with fludarabine 142
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 139
Non-tunnelled central venous catheters in adult stem cell transplantation recipients: an effective option 138
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 138
High-dose glucocorticoids plus Ofatumumab in fludarabine/alemtuzumab-resistant B-cell chronic lymphocytic leukemia 133
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 133
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors. A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (Gitmo) 133
Allogeneic hematopoietic stem cell transplantation in therapy-related myeloid neoplasms (t-MN) of the adult: Monocentric observational study and review of the literature 131
Unselected donor-derived hematopoietic stem cells boost for Chimeric Antigen Receptor T-cell associated hematotoxicity 129
Treatment-free remission in chronic myeloid leukemia patients treated front-line with nilotinib: 10-year followup of the GIMEMA CML 0307 study 128
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 128
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 127
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 127
Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: Effects on response rate, toxicity and outcome 126
Subcutaneous immunoglobulins in chronic lymphocytic leukemia with secondary antibody deficiency. A monocentric experience during Covid-19 pandemics 126
Pure red cell aplasia among ABO mismatched hematopoietic stem cell transplant recipients: a 13-years retrospective study and literature review 125
Donor cell-derived myelofibrosis relapse after allogeneic stem cell transplantation 123
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 123
Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid 123
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T cells 122
Age influences initial dose and compliance to imatinib in chronic myeloid leukemia elderly patients but concomitant comorbidities appear to influence overall and event-free survival 121
Inflammation and acute cardiotoxicity in adult hematological patients treated with CAR-T cells: results from a pilot proof-of-concept study 120
Efficacy and Tolerability of First Line Arsenic Trioxide in Combination With All-Trans Retinoic Acid in Patients With Acute Promyelocytic Leukemia: Real Life Experience 117
Unrelated cord blood transplantation and post-transplant cyclophosphamide 115
Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All-Trans Retinoic Acid: A Monocentric Experience 114
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 114
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 114
Acute graft versus host disease 1976-2020: reduced incidence and predictive factors 113
Peripheral Blood Hemopoietic Stem Cell Mobilization Regimens in POEMS Syndrome: A Retrospective Study at 2 Hematologic Italian Centers 113
Effect of HLA mismatch on post-transplant infections in allogeneic hematopoietic stem cell transplantation with PTCy-based GvHD prophylaxis 112
Unlocking Predictive Power: Quantitative Assessment of CAR-T Expansion with Digital Droplet Polymerase Chain Reaction (ddPCR) 112
the concomitance of lymphoma and breast carcinoma in the bone 112
Risk factors for hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation in a letermovir-exposed CMV-free population receiving PTCy 112
The impact of donor-specific antibodies’ presence on the outcome post-allogeneic hematopoietic stem cell transplantation: a survey from a single center 111
Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: Effects on response rate, toxicity and outcome 109
Second haploidentical stem cell transplantation for primary graft failure 109
CAR-T from cord blood in a patient with Ph+ acute lymphoblastic leukemia relapsing after hematopoietic stem cell transplantation 108
Imatinib in very elderly patients with chronic myeloid leukemia in chronic phase: a retrospective study 108
Chlorambucil PLUS Rituximab As FRONT-LINE THERAPY in Elderly or Unfit Patients Affected by B-CELL Chronic Lymphocytic Leukemia: Results of A Single-Centre Retrospective Analysis 108
Haploidentical bone marrow transplantation for AML in remission following TBF conditioning: a long-term follow up 108
Day +60 WT1 assessment on CD34 selected bone marrow better predicts relapse and mortality after allogeneic stem cell transplantation in acute myeloid leukemia patients 107
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-t Cells 107
Coagulopathy in CAR-T: Critical concern or mere blip? 107
The CD4/CD8 ratio of infused CD19-CAR-T is a prognostic factor for efficacy and toxicity 107
CAR-T treatment is safe and effective in adult patients with Down syndrome and B-cell acute lymphoblastic leukemia (B-ALL) 107
Post-transplant cyclophosphamide with Sirolimus or Cyclosporine for GvHD prophylaxis in matched related and unrelated transplantation: a two-center analysis on 213 consecutive patients 105
Risk of infectious complications in patients with chronic lymphocytic leukemia in the era of BCR inhibitors: a retrospective single institution experience 105
HBV reactivation in CLL patients with occult HBV infection treated with ibrutinib without viral prophylaxis. 105
Allogeneic Hemopoietic Stem Cell Transplants in Patients with Acute Myeloid Leukemia (AML) Prepared with Busulfan and Fludarabine (BUFLU) or Thiotepa, Busulfan, and Fludarabine (TBF): A Retrospective Study 105
Eltrombopag for the treatment of poor graft function following allogeneic stem cell transplant: a retrospective multicenter study 104
Triple post transplant cyclophosphamide (PTCY) based GVHD prophylaxis: HLA matched versus HLA haploidentical transplants. 103
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 101
Unrelated cord blood transplantation and post-transplant cyclophosphamide 99
Prevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience 98
Impact of SARS-CoV-2 vaccination and passive prophylaxis with tixagevimab/cilgavimab on CAR-T patients: a three-year regional experience from the Italian covid pandemic 97
Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All-Trans Retinoic Acid: A Monocentric Experience 97
Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline 97
Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study 97
Baseline Tumor Burden Assessed With AI-Guided PET/CT Total Metabolic Tumor Volume (TMTV) and LDH Levels Predict Efficacy of CAR-T in Aggressive B-Cell Lymphoma 96
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 96
Treatment patterns in patients with chronic-phase chronic myeloid leukaemia in routine clinical practice: The simplicity Italian population 96
next-generation sequencing improves BCR-ABL1 mutation detection in Philadelphia chromosome -positive acute lymphoblastic leukemia 95
Risk of infectious complications in patients with chronic lymphocytic leukemia in the era of BCR inhibitors: a retrospective single institution experience 95
Successful management of chronic disseminated candidiasis in hematologic patients treated with high-dose liposomal amphotericin B: a retrospective study of the SEIFEM registry 94
allogenic hemopoietic stem cell transplant in patients with acute myeloid leukemia prepared with busulfan and fludarabine or thiotepa busulfan and fludarabine a retrospective study 94
Vascular inflammation in patients undergoing anti-CD19 chimeric antigen receptor-T cells for haematologic malignancies: a call for cardiovascular surveillance 93
Dasatinib is safe and effective in unselected chronic myeloid leukaemia elderly patients resistant/intolerant to imatinib 93
Low risk of hepatitis B virus reactivation in patients with resolved infection and chronic myeloid leukemia treated with tyrosine kinase inhibitors 93
Chronic myeloid leukaemia with extreme thrombocytosis at presentation: Incidence, clinical findings and outcome 93
The concomitance of lymphoma and breast carcinoma in the bone 93
Days alive outside hospital and readmissions in patients undergoing allogeneic transplants from identical siblings or alternative donors 92
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 91
Impact of Covid 19 pandemic on hematopoietic stem cell transplantation activities: Report from a single center 91
Totale 13.506
Salva come PNG Salva come JPEG
Categoria #
all - tutte 83.026
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.026
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022916 76 39 34 41 65 24 18 139 49 62 181 188
2022/20232.046 254 244 148 252 209 274 95 150 258 52 83 27
2023/20241.325 45 356 62 91 47 154 101 77 28 70 122 172
2024/20253.302 100 82 220 175 257 117 117 133 437 316 759 589
2025/20267.559 1.127 254 484 772 1.139 416 1.234 439 520 600 348 226
2026/2027267 267 0 0 0 0 0 0 0 0 0 0 0
Totale 18.960